Efficacy and safety of odanacatib in the treatment of postmenopausal women with osteoporosis: a meta-analysis

Abstract Background Osteoporosis, a systemic skeletal disease, seriously affects the quality of life in postmenopausal women. As one type of cathepsin K (CatK) inhibitor, odanacatib (ODN) is a fresh medication for osteoporosis. Considering the potential of ODN, we further examined the effect and saf...

Full description

Bibliographic Details
Published in:	Journal of Orthopaedic Surgery and Research
Main Authors:	Jiaxuan Li, Qi Qiu, Shide Jiang, Jianfeng Sun, Volotovski Pavel, Yusheng Li
Format:	Article
Language:	English
Published:	BMC 2024-08-01
Subjects:	Odanacatib Postmenopausal osteoporosis Efficacy Safety
Online Access:	https://doi.org/10.1186/s13018-024-05008-z

Similar Items

A multifunctional drug consisting of tetracycline conjugated with odanacatib for efficient periodontitis therapy
by: Dengke Li, et al.
Published: (2022-10-01)

Efficacy and safety of denosumab and teriparatide versus oral bisphosphonates to treat postmenopausal osteoporosis: a systematic review and meta-analysis
by: Jia Yang, et al.
Published: (2024-09-01)

Long-term treatment with odanacatib maintains normal trabecular biomechanical properties in ovariectomized adult monkeys as demonstrated by micro-CT-based finite element analysis
by: Antonio Cabal, et al.
Published: (2017-06-01)

Odanacatib, a Cathepsin K Cysteine Protease Inhibitor, Kills Hookworm In Vivo
by: Jon J. Vermeire, et al.
Published: (2016-07-01)

Cellular and molecular mechanisms of osteoporosis: current concepts and future direction treatment
by: A. T. Dolzhenko, et al.
Published: (2016-06-01)

Quality use of medicines: The postmenopausal woman with osteoporosis
by: Andy Gray, et al.
Published: (2003-05-01)

Ubiquitylomes Analysis of the Whole blood in Postmenopausal Osteoporosis Patients and healthy Postmenopausal Women
by: Yi‐ran Yang, et al.
Published: (2019-12-01)

Teriparatide in postmenopausal osteoporosis: uncovering novel insights into efficacy and safety compared to other treatments – a systematic review and meta-analysis
by: Djandan Tadum Arthur Vithran, et al.
Published: (2024-09-01)

Efficacy and safety of pharmacologic therapies for prevention of osteoporotic vertebral fractures in postmenopausal women
by: Fei-Long Wei, et al.
Published: (2023-02-01)

Efficacy and safety of bivalos therapy for postmenopausal osteoporosis. results of russian multicenter trial
by: L Ia Rozhinskaia, et al.
Published: (2008-05-01)

Irisin and Its Role in Postmenopausal Osteoporosis and Sarcopenia
by: Irene Falsetti, et al.
Published: (2024-04-01)

THE ROLE OF CYTOKINE SYSTEM RANKL-RANK-OPG AND CATHEPSIN K IN THE PATHOGENESIS OF OSTEOPOROSIS: ACHIEVEMENTS AND PERSPECTIVES IN THE TREATMENT OF DISEASE
by: S. Sagalovsky, et al.
Published: (2015-10-01)

SCIMP: A Novel Targeted Gene for Postmenopausal Osteoporosis Progression
by: Xiaolei Sun, et al.
Published: (2023-05-01)

Prevalence of osteoporosis in postmenopausal women at Srinagarind Hospital, Khon Kaen University
by: Surangtip Surangtip, et al.
Published: (2010-03-01)

The efficacy and safety of denosumab in postmenopausal women with osteoporosis previously treated with bisphosphonates: A review
by: Yilin Zhu, et al.
Published: (2020-05-01)

Identification of key ferrotoposis-related therapeutic targets in icariin efficacy for postmenopausal osteoporosis treatment
by: Dingbang Xie, et al.
Published: (2024-06-01)

OSTEOPOROSIS: ASSESSMENT OF A RISK FOR RECURRENT LOW-TRAUMA FRACTURES IN POSTMENOPAUSAL WOMEN
by: O. V. Dobrovolskaya, et al.
Published: (2016-03-01)

Sarcopenia and Balance in Community-dwelling Women with Postmenopausal Osteoporosis
by: Bilinç Doğruöz Karatekin, et al.
Published: (2021-06-01)

Efficacy and safety of zoledronic acid in the treatment of osteoporosis: A meta-analysis of randomized controlled trials
by: Jianfeng Sun, et al.
Published: (2024-07-01)

Comprarison of Risendronate and Raloxifene Treatment in Postmenopausal Osteoporosis - Original Investigation
by: Dilek Koç Yılmaz, et al.
Published: (2006-09-01)

Vertebral Fracture in Postmenopausal Women with and without Osteoporosis
by: Merih Özgen, et al.
Published: (2017-08-01)

Osteoporosis in women in menopause/postmenopause: what to do?
by: E. V. Kulchavenya, et al.
Published: (2021-01-01)

Evaluation of Serum Osteocalcin Level in Iraqi Postmenopausal Women with Primary Osteoporosis
by: Rana A. Hamdi
Published: (2013-07-01)

Identification and evaluation of circulating exosomal miRNAs for the diagnosis of postmenopausal osteoporosis
by: Zhibang Sun, et al.
Published: (2023-07-01)

RISK ASSESSMENT FOR OSTEOPOROSIS IN POSTMENOPAUSAL WOMEN
by: Z. Shukerova
Published: (2020-12-01)

Effect of Teriparatide in Postmenopausal Women with Osteoporosis
by: Masoud Shayestehazar, et al.
Published: (2018-12-01)

β2 -Microglobulin Levels in Patients with Postmenopausal Osteoporosis
by: Funda Taşçıoğlu, et al.
Published: (2003-06-01)

The Relationship Between Postmenopausal Osteoporosis and Autophagic Gene Polymorphisms
by: Türkan Turgay, et al.
Published: (2020-08-01)

Osteoporosis treatment in postmenopausal women with pre-existing fracture
by: Ming-Huei Cheng, et al.
Published: (2012-06-01)

The Effect of Continous or Intermittent Calcitonin in the Treatment of Postmenopausal Osteoporosis
by: F. Taşçıoğlu, et al.
Published: (2002-03-01)

Pathogenetic treatment with strontium ranelate in women with postmenopausal osteoporosis
by: Olga Borisovna Yershova
Published: (2010-12-01)

Outcomes of Treatment in Patients with Elderly Postmenopausal Osteoporosis: Comparision of Oral and Parenteral Bisphosphonates
by: Ahmet Aslan, et al.
Published: (2018-08-01)

The Comparison of Effects of Alendronate and Raloxifene Treatment in Postmenopausal Women with Osteoporosis - Original Investigation
by: Gülcan Gürer, et al.
Published: (2006-03-01)

The application of FRAX values to determine the distribution of risk factors for Osteoporosis in Postmenopausal women
by: Tri Hari Irfani
Published: (2016-03-01)

Analysis of radiomorphometric indices in postmenopausal patients with osteoporosis: Case report and literature review
by: Ioana Madalina Lescai, et al.
Published: (2021-06-01)

THE APPLICATION OF FRAX VALUES TO DETERMINE THE DISTRIBUTION OF RISK FACTORS FOR OSTEOPOROSIS IN POSTMENOPAUSAL WOMEN
by: Tri Hari Irfani
Published: (2016-03-01)

Is abaloparatide more efficacious on increasing bone mineral density than teriparatide for women with postmenopausal osteoporosis? An updated meta-analysis
by: Pan Hong, et al.
Published: (2023-02-01)

Safety and efficacy of sequential treatments for postmenopausal osteoporosis: a network meta-analysis of randomised controlled trialsResearch in context
by: Yu-Xin Han, et al.
Published: (2024-02-01)

Epidemiology of osteoporosis in postmenopausal women aged 47 to 60 years
by: Meiyanti
Published: (2010-12-01)

Plasma leptin values in postmenopausal women with osteoporosis
by: Hikmet Kocyigit, et al.
Published: (2013-08-01)